The behavior of alpha-synuclein in neurons
- PMID: 20187244
- DOI: 10.1002/mds.22722
The behavior of alpha-synuclein in neurons
Abstract
Despite considerable evidence linking alpha-synuclein with membranes in vitro, it has proven difficult to demonstrate membrane association of the protein in vivo. alpha-Synuclein localizes to the nerve terminal, but biochemical experiments have not revealed a tight association with membranes. To address the dynamics of the protein in live cells, we have used photobleaching and found that alpha-synuclein exhibits high mobility, although distinctly less than an entirely soluble protein. Further, neural activity controls the distribution of alpha-synuclein, causing its dispersion from the synapse. In addition to the presumed role of alpha-synuclein dynamics in synaptic function, changes in its physiological behavior may underlie the pathological changes associated with Parkinson's disease.
Similar articles
-
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10. Brain. 2010. PMID: 19903734
-
Staging of alpha-synuclein in the olfactory bulb in a model of Parkinson's disease: cell types involved.Mov Disord. 2010 Aug 15;25(11):1701-7. doi: 10.1002/mds.23197. Mov Disord. 2010. PMID: 20574962
-
Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells.J Neurochem. 2006 May;97(4):1071-7. doi: 10.1111/j.1471-4159.2006.03803.x. Epub 2006 Apr 5. J Neurochem. 2006. PMID: 16606366
-
Controlling the mass action of alpha-synuclein in Parkinson's disease.J Neurochem. 2008 Oct;107(2):303-16. doi: 10.1111/j.1471-4159.2008.05612.x. Epub 2008 Sep 2. J Neurochem. 2008. PMID: 18691382 Review.
-
Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms.Exp Neurol. 2008 Jan;209(1):12-21. doi: 10.1016/j.expneurol.2007.07.006. Epub 2007 Jul 17. Exp Neurol. 2008. PMID: 17706644 Review.
Cited by
-
Can the lack of fibrillar form of alpha-synuclein in Lewy bodies be explained by its catalytic activity?Math Biosci. 2022 Feb;344:108754. doi: 10.1016/j.mbs.2021.108754. Epub 2021 Dec 7. Math Biosci. 2022. PMID: 34890628 Free PMC article.
-
Overexpression of alpha-synuclein promotes both cell proliferation and cell toxicity in human SH-SY5Y neuroblastoma cells.J Adv Res. 2020 Jan 22;23:37-45. doi: 10.1016/j.jare.2020.01.009. eCollection 2020 May. J Adv Res. 2020. PMID: 32071790 Free PMC article.
-
Rafts, Nanoparticles and Neural Disease.Nanomaterials (Basel). 2012 Aug 6;2(3):217-250. doi: 10.3390/nano2030217. Nanomaterials (Basel). 2012. PMID: 28348305 Free PMC article. Review.
-
Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation.Nat Chem Biol. 2015 Mar;11(3):229-34. doi: 10.1038/nchembio.1750. Epub 2015 Feb 2. Nat Chem Biol. 2015. PMID: 25643172 Free PMC article.
-
VAMP2 regulates phase separation of α-synuclein.Nat Cell Biol. 2024 Aug;26(8):1296-1308. doi: 10.1038/s41556-024-01451-6. Epub 2024 Jul 1. Nat Cell Biol. 2024. PMID: 38951707 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical